University Hospital Regensburg
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- 4.9K
- Market Cap
- -
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas
Not yet recruiting
- Conditions
- Embryonal TumorGlioma, MalignantMedulloblastomaEpendymoma
- Interventions
- Diagnostic Test: Tissue, blood, cerebrospinal-spinal fluid
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 72
- Registration Number
- NCT06323408
Impact of Surgical Mask, FFP2 Mask and FFP3 Mask (With and Without Exhalation Valve) on Exercise Tolerance and Blood Gas Parameters of Patients With Known Lung Disease and Long-term Oxygen Therapy
Completed
- Conditions
- Longterm Oxygen TherapyFace Mask
- Interventions
- Diagnostic Test: 6-MWTDiagnostic Test: Spiroergometry
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 72
- Registration Number
- NCT05931016
- Locations
- 🇩🇪
Klinik Donaustauf, Donaustauf, Bavaria, Germany
Investigating the Equivalence of the EORTC QLQ-C30 and the QLQ-F17
Completed
- Conditions
- Quality of LifeCancer
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 2672
- Registration Number
- NCT05479682
- Locations
- 🇩🇪
Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany
Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
Completed
- Conditions
- AngiogenesisGlioblastoma
- Interventions
- Other: Observation of neurological deficits
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2021-07-23
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 203
- Registration Number
- NCT04974983
- Locations
- 🇩🇪
University Hospital Regensburg, Regensburg, Germany
Systematic Assessment of Self-help Tools for the Management of Chronic Tinnitus
Not Applicable
- Conditions
- Tinnitus, Subjective
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 50
- Registration Number
- NCT04069364
- Locations
- 🇩🇪
University of Regensburg, Regensburg, Germany
Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus
Completed
- Conditions
- Quality of Life
- Interventions
- Behavioral: HRQL
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2017-10-30
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 220
- Registration Number
- NCT03324919
- Locations
- 🇩🇪
University Hospital Regensburg, Regensburg, Bavaria, Germany
Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation
Completed
- Conditions
- Pulmonary HypertensionMitral Valve Regurgitation
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 38
- Registration Number
- NCT03154034
- Locations
- 🇩🇪
University Hospital Regensburg - Department of Internal Medicine II, Regensburg, Germany
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
Phase 2
Terminated
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 10
- Registration Number
- NCT02942758
- Locations
- 🇩🇪
University Hospital Regensburg, Regensburg, Germany
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
Phase 2
- Conditions
- Non-Squamous Cell Lung CancerSquamous Cell Lung CancerNon-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 86
- Registration Number
- NCT02852083
- Locations
- 🇩🇪
MVZ am Klinikum GmbH, Passau, Bavaria, Germany
🇩🇪Klinik für Innere Medizin, Homburg/Saar, Saarland, Germany
🇩🇪St. Antonius-Hospital, Eschweiler, Nordrhein-Westfalen, Germany
Psychometric Properties of the EORTC QLQ-LC29
Completed
- Conditions
- Lung Cancer
- Interventions
- Other: Targeted therapyOther: SurgeryOther: ImmunotherapyOther: Radiochemotherapy
- First Posted Date
- 2016-04-20
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- University Hospital Regensburg
- Target Recruit Count
- 523
- Registration Number
- NCT02745691
- Locations
- 🇩🇪
Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany
© Copyright 2025. All Rights Reserved by MedPath